Cargando…
Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design
Anti-microbial resistance is a rising global healthcare concern that needs urgent attention as growing number of infections become difficult to treat with the currently available antibiotics. This is particularly true for mycobacterial infections like tuberculosis and leprosy and those with emerging...
Autores principales: | Thomas, Sherine E., McCarthy, William J., El Bakali, Jamal, Brown, Karen P., Kim, So Yeon, Blaszczyk, Michal, Mendes, Vítor, Abell, Chris, Floto, R. Andres, Coyne, Anthony G., Blundell, Tom L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197168/ https://www.ncbi.nlm.nih.gov/pubmed/35712348 http://dx.doi.org/10.3389/fmolb.2022.880432 |
Ejemplares similares
-
Development of
Inhibitors against Mycobacterium
abscessus tRNA (m(1)G37) Methyltransferase
(TrmD) Using Fragment-Based Approaches
por: Whitehouse, Andrew J., et al.
Publicado: (2019) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022) -
Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
por: Thomas, Sherine E., et al.
Publicado: (2019) -
Fragment-Based
Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020) -
Correction to Fragment-Based
Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)